Beauty Devices

Korea MFDS Mandates Dual Certification for Beauty Device Lithium Cells

Beauty Industry Analyst
Publication Date:May 06, 2026
Views:
Korea MFDS Mandates Dual Certification for Beauty Device Lithium Cells

On May 4, 2026, the Korean Ministry of Food and Drug Safety (MFDS) issued a technical notice requiring all rechargeable lithium cells used in cosmetic devices—including radiofrequency, microcurrent, and LED-based instruments—to comply with both UN38.3 transport safety testing and the newly adopted Korean national standard KC 62133-2:2026. This requirement directly affects manufacturers, exporters, and certification service providers engaged in the Korean beauty device market.

Event Overview

The Korean Ministry of Food and Drug Safety (MFDS) published a technical notice on May 4, 2026, stipulating that all cosmetic instruments containing rechargeable lithium cells must pass two mandatory certifications: UN38.3 (for safe air/sea transport of lithium batteries) and KC 62133-2:2026 (the updated Korean safety standard for secondary lithium cells and batteries). The previous version, KC 62133-1, is no longer valid as of the notice’s issuance date. Compliance is required for Korea Certification (KC) registration of finished devices; failure to meet both standards will result in registration rejection.

Industries Affected

Original Equipment Manufacturers (OEMs), particularly China-based

OEMs supplying battery-integrated beauty devices to Korean importers or brand owners are directly impacted because the notice mandates dual certification at the cell level—and requires updated battery module documentation and full-device safety reports aligned with KC 62133-2:2026. Since many Chinese OEMs previously relied on KC 62133-1–certified cells or generic UN38.3 test reports, requalification may delay production timelines and increase compliance costs.

Component Suppliers (Lithium Cell & Battery Pack Providers)

Suppliers of lithium cells or pre-assembled battery modules must now ensure their products carry valid KC 62133-2:2026 certification—issued by an MFDS-recognized Korean certification body—not just UN38.3. Cells certified under older versions or non-Korean schemes (e.g., IEC 62133-2:2017 without KC marking) do not satisfy the new requirement. This narrows the pool of eligible components for KC-registered devices.

KC Certification Agents & Testing Laboratories

Third-party service providers supporting KC registration must update their test protocols and reporting templates to reflect KC 62133-2:2026’s revised clauses—including thermal runaway propagation tests, enhanced mechanical abuse requirements, and updated labeling provisions. Labs not yet accredited for KC 62133-2:2026 may be unable to issue valid reports for new submissions.

Distributors & Brand Owners Marketing in Korea

Brands distributing RF, microcurrent, or LED beauty devices in Korea must verify that every unit contains cells bearing both UN38.3 test evidence and KC 62133-2:2026 certification. Inventory already cleared under KC 62133-1 remains unaffected—but new batches require full re-evaluation. Failure to confirm dual compliance risks post-market noncompliance findings during MFDS inspections or customs clearance.

Key Considerations and Recommended Actions

Monitor official KC implementation guidance from MFDS and KATS

The notice confirms the effective date and scope but does not yet clarify transition periods for existing stock or grandfathering rules for devices already in KC review. Stakeholders should track updates from the Korean Agency for Technology and Standards (KATS) and MFDS announcements regarding enforcement timelines and acceptable evidence formats.

Verify cell-level certification status before finalizing BOMs

Procurement teams should request updated KC 62133-2:2026 certificates—not just test reports—for all lithium cells, along with proof of KC mark authorization from the issuing body. Cross-check certificate numbers against KATS’ publicly accessible KC database where available.

Update both battery module and full-device safety documentation

Compliance is not satisfied by cell-level certification alone. OEMs must submit revised battery module safety assessments and integrated device-level safety reports (e.g., referencing IEC 62368-1 or KC 62368-1 where applicable) that explicitly reference KC 62133-2:2026 as the basis for cell evaluation.

Engage KC-accredited labs early for test scheduling

Lead times for KC 62133-2:2026 testing—including mandatory preconditioning, cycle life verification, and thermal shock validation—may extend beyond standard UN38.3 turnaround. Early engagement helps avoid bottlenecks ahead of planned KC application deadlines.

Editorial Observation / Industry Perspective

Observably, this notice signals a tightening of regulatory alignment between battery safety and medical-cosmetic device oversight in Korea—not a sudden policy shift, but a formalized convergence of transport and end-use safety expectations. Analysis shows MFDS is treating lithium-powered beauty devices with increasing scrutiny akin to low-risk medical equipment, especially given their direct skin contact and prolonged operation profiles. From an industry standpoint, the dual-certification mandate is less a transitional measure and more a structural recalibration: it elevates cell-level due diligence from a supply chain checkpoint to a prerequisite for market access. Continued attention is warranted as KATS may issue supplementary interpretation documents later in 2026.

Korea MFDS Mandates Dual Certification for Beauty Device Lithium Cells

This notice underscores that compliance for beauty electronics entering Korea has evolved from a product-level assessment to a layered, component-specific obligation—with lithium cells now carrying independent, non-delegable certification weight. It is best understood not as an isolated regulatory update, but as a marker of broader regulatory maturation in the Korean personal wellness device sector—where safety accountability is increasingly distributed across the value chain rather than centralized at the final device stage.

Source: Korean Ministry of Food and Drug Safety (MFDS), Technical Notice dated May 4, 2026. Note: Ongoing monitoring is recommended for KATS-issued implementation guidelines and potential clarification notices.

Related Intelligence